---
title: 'Indirect effectiveness of a novel SAR-COV-2 vaccine (SCB-2019) in unvaccinated
  household contacts in the Philippines: a cluster randomised analysis'
date: '2024-09-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39218309/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240902183516&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Though observational evidence supports indirect effects
  of SARS-CoV-2 vaccines, randomised experiments are lacking. To address this gap,
  the double-blinded, prospective follow-up of the household contacts (HHCs) of Philippine
  participants of the individually-randomised, placebo-controlled trial of the adjuvanted-subunit
  protein COVID-19 vaccine, SCB-2019, (EudraCT, 2020-004272-17; ClinicalTrials.gov,
  NCT04672395) was analyzed in a cluster-randomised ...'
disable_comments: true
---
BACKGROUND: Though observational evidence supports indirect effects of SARS-CoV-2 vaccines, randomised experiments are lacking. To address this gap, the double-blinded, prospective follow-up of the household contacts (HHCs) of Philippine participants of the individually-randomised, placebo-controlled trial of the adjuvanted-subunit protein COVID-19 vaccine, SCB-2019, (EudraCT, 2020-004272-17; ClinicalTrials.gov, NCT04672395) was analyzed in a cluster-randomised ...